微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 6.96% | -34.4% | 63% | 50/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.27% | -39.86% | 139.89% | 48/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.78% | -59.17% | -85.04% | 68/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 11.9% | -1.57% | 12.16% | 20/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 10.61% | -15.46% | 49.44% | 22/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 7.1% | 4.72% | 62.84% | 19/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 4.36% | 22.82% | -63.94% | 13/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 12.09% | -1.79% | -3.67% | 29/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 12.55% | 21.49% | 85.1% | 20/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 6.78% | 5.77% | 90.99% | 28/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.55% | 1.72% | -71.16% | 26/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 12.31% | -33.28% | 19.17% | 32/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 10.33% | -26.48% | 61.15% | 30/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 6.41% | -31.22% | 83.67% | 37/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.49% | 2% | -81.08% | 32/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 18.45% | 7.64% | 31.32% | 24/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 14.05% | 2% | 50.75% | 19/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 9.32% | 4.02% | -45.62% | 24/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2019-12-31 | 17.14% | -12.37% | 91.29% | 26/160 | 2.78% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-06-30 | 8.96% | 2% | -54.19% | 18/160 | 5.05% | 誉衡药业 | 35.56% | 行业排名> |
| 2018-12-31 | 19.56% | -10.11% | -10.11% | 16/160 | 7.09% | 奥赛康 | 35% | 行业排名> |
| 2017-12-31 | 21.76% | -6.09% | -6.09% | 9/160 | 9.66% | 奥赛康 | 28.15% | 行业排名> |
| 2016-12-31 | 23.17% | -7.02% | -7.02% | 15/160 | 6.33% | 宏源药业 | 21.91% | 行业排名> |